Lisa Toto, Pasquale Viggiano, Alberto Quarta, Mariaoliva Grassi, Chiara De Nicola, Raffaella Aloia, Rossella D'Aloisio, Giacomo Boscia, Francesco Boscia, Annamaria Porreca, Marta Di Nicola, Maria Cristina Savastano, Rodolfo Mastropasqua
UNLABELLED: (348 words) Introduction: The purpose of this study is to investigate long-term outcomes of intravitreal injections (IVI) of anti-vascular endothelial growth factor (VEGF) in neovascular age-related macular degeneration (nAMD) with type 3 macular neovascularization (MNV). METHODS: This retrospective study included 19 eyes of 17 patients with nAMD and type 3 MNV treated with anti-VEGF IVI with a loading dose and PRN regimen. Best corrected visual acuity (BCVA), central macular thickness (CMT), presence of macular intraretinal fluid (IRF) and subretinal fluid (SRF), flow area (FA), subfoveal choroidal thickness (CT) and macular atrophy (MA) were assessed at baseline (T0) and during follow up (T1, post loading phase; T2, one year; T3, two years, T4>2 years)...
April 15, 2024: Ophthalmic Research